Jayesh Chaudhary

Upcycled ingredients have a great sustainability story, but to succeed, they need clinical substantiation to demonstrate their benefits and truly differentiate.

Participant selection can be an important part of achieving consistent outcomes across study population. Phenotype-based recruitment, for example, is one strategy that can help achieve clearer results compared to more heterogeneous populations.

Choosing design over proximity in clinical research. Why robust design, objective end points, and clear biology outweigh geography in FDA and EMA reviews.

Competent and Reliable Scientific Evidence (CARSE) is a requirement set by the Federal Trade Commission, but how the agency defined "competent" is unclear. Let's unpack what makes a research team competent.

A long-held misconception that data generated in non-Caucasian populations has limited relevance for Caucasian markets continues to influence study protocol design despite the growing ethnic diversity of Western markets. However, trials designed around mechanism-driven end points do translate across populations, meaning that researchers can reliably study non-Caucasian populations, reducing cost and operational complexity of trials.

How building clinical evidence through multiple exploratory studies to inform clinical trial designs reduce risk and help make more commercially viable products.